Wedbush analyst David Nierengarten reiterated an Outperform rating and lifted his price target on Medivation (NASDAQ: MDVN) to $66.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE